Cervical mass after cytotoxic chemotherapy, secondary malignancy or epiphenomenon?
Relapsed blastic natural killer cell leukaemia with splenic rupture
The evolution towards ambulatory and day-case management of febrile neutropenia
Denis Burkitt and his contribution to haematology/oncology
JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells
Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP
Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells
Fracture risk in patients with monoclonal gammopathy of undetermined significance
The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9
Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma
Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children
High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes
Inherited and de novo von Willebrand disease ‘Vicenza’ in UK families with the R1205H mutation
Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody
The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura
Gene expression analysis of myeloid and lymphoid lineage markers during mouse haematopoiesis
PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera
Fanconi anaemia
Fanconi anaemia – response to Manoharan
2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease
2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease
British Society for Haematology/Lifeblood/British Society for Haemostasis and Thrombosis Joint Award
Novo Nordisk Haemophilia Foundation website